©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Gap Junction Protein Connexin43 Is Degraded via the Ubiquitin Proteasome Pathway (*)

(Received for publication, June 7, 1995; and in revised form, August 9, 1995)

James G. Laing (§) Eric C. Beyer (1)(¶)

From the Departments of Pediatrics and Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri 63110

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

We investigated the degradation of the gap junction protein connexin43 in E36 Chinese hamster ovary cells and rat cardiomyocyte-derived BWEM cells. Treatment of E36 cells with the lysosomotropic amine, primaquine, for 16 h doubled the amount of connexin43 detected by immunoblotting and modestly increased the half-life of connexin43 in pulse-chase studies, suggesting that the lysosome played a minor role in connexin43 proteolysis. In contrast, treatment with the proteasomal inhibitor N-acetyl-L-leucyl-L-leucinyl-norleucinal led to a 6-fold accumulation of connexin43 and increased the half-life of connexin43 to 9 h. The role of ubiquitin in connexin43 degradation was examined in an E36-derived mutant, ts20, which contains a thermolabile ubiquitin-activating enzyme, E1. E36 and ts20 cells grown at the permissive temperature contained similar amounts of connexin43 detectable by immunoblotting. Heat treatment dramatically reduced the amount of connexin43 detected in E36 cells, while connexin43 levels in heat-treated ts20 cells did not change. E36 cells that were heat-treated in the presence of N-acetyl-L-leucyl-L-leucinyl-norleucinal did not lose their connexin43. Pulse-chase experiments showed the reversibility of the block to connexin43 degradation in ts20 cells that were returned to the permissive temperature. Finally, sequential immunoprecipitation using anti-connexin43 and anti-ubiquitin antibodies demonstrated polyubiquitination of connexin43. These results indicate that ubiquitin-mediated proteasomal proteolysis may be the major mechanism of degradation of connexin43.


INTRODUCTION

Gap junctions are plasma membrane structures that contain groups of channels that allow the passage of ions and small molecules between adjacent cells(1) . While their microscopic appearance suggests that gap junctions might be stable structures, in fact, studies have suggested that they are quite dynamic. The turnover and degradation of gap junctions may have profound consequences for intercellular interactions in several physiological or pathological situations. Examples are as follows: hepatocyte gap junctions are rapidly degraded, and cells uncouple after partial hepatectomy followed by gap junction resynthesis associated with liver regeneration(2) ; ventricular myocyte interconnections at gap junctions are remodeled and redistributed in the zones bordering healed myocardial infarcts in a manner that may predispose to reentrant arrhythmias(3) , and gap junctions in uterine myometrium are synthesized rapidly at term and degraded rapidly after delivery leading to uncoupling of these smooth muscle cells(4) .

The turnover of gap junctions and their constituent proteins also appears to be rapid in normal adult organs and in cultured cells. Fallon and Goodenough (5) determined that hepatic gap junctions have a half-life of about 5 h in vivo. Further turnover studies were facilitated by the molecular cloning of the subunit gap junction proteins (connexins) and the development of specific antibodies. Use of these antibodies for immunoprecipitation of radioactively labeled connexins in pulse-chase experiments has shown that connexin43 (Cx43), (^1)connexin26, connexin32, and connexin45 have half-lives of 2-3 h in cultured cells(6, 7, 8, 9) . Compared with many other membrane proteins, gap junction proteins turn over rather rapidly. These findings suggest that even under normal conditions, synthesis and degradation of gap junctional channels are very dynamic processes and may provide major mechanisms for the regulation of intercellular coupling and potential remodeling of cellular connections.

The major pathways of protein degradation include lysosomal proteolysis, ubiquitin-dependent lysosomal proteolysis (autophagy), ubiquitin-dependent proteasomal proteolysis, and ubiquitin-independent proteasomal proteolysis. Lysosomes are predominantly involved in the degradation of internalized extracellular materials and receptors. Ubiquitination may regulate the proteolysis of many short-lived and abnormal cellular proteins(10) . The proteasome may degrade proteins in a non-ubiquitin-dependent manner (11, 12, 13) , and ubiquitin is involved in autophagy(14) .

To elucidate mechanisms of gap junction degradation, we characterized Cx43 turnover and degradation in E36 Chinese hamster ovary cells, in rat cardiac myocyte-derived BWEM cells, and in a mutant of the E36 cells (ts20). The ts20 cells have a temperature-sensitive defect in the ubiquitin-activating protein, E1, and fail to degrade short-lived or abnormal proteins at the restrictive temperature(10) .


EXPERIMENTAL PROCEDURES

Materials

All reagents were obtained from Sigma unless otherwise noted. The protease inhibitors aprotinin, pefabloc, leupeptin, EDTA, antipain, bestatin, and E-64 were purchased from Boehringer Mannheim Biochemicals. A rabbit antiserum directed against a synthetic peptide representing amino acids 252-271 in Cx43 was produced previously and has been extensively characterized(15) . Mouse monoclonal antibodies (IgG1) against Cx43 (amino acids 252-270) or against ubiquitin were purchased from Chemicon (Temecula, CA).

Cell Culture

E36 and ts20 cells were provided by Dr. Alan L. Schwartz (Washington University School of Medicine). E36 and ts20 cells were grown at 30.5 °C in minimum essential medium supplemented with 4.5 g of glucose/liter (Life Technologies, Inc.), 10% fetal calf serum (JRH Biosciences, Lenexa, KS), 100 units/ml penicillin, and 100 µg/ml streptomycin (Life Technologies, Inc.). BWEM cells were grown at 37 °C in 50% Dulbecco's modified Eagle's medium, 50% Hams' F-12 medium buffered with HEPES (Life Technologies, Inc.) supplemented with 4% fetal calf serum (JRH Biosciences, Lenexa, KS) and 100 units/ml penicillin and 100 µg/ml streptomycin (Life Technologies, Inc.).

Heat Treatment and Metabolic Labeling of Cells

Cells were heat-treated for 1 h at 44 °C in normal medium buffered with HEPES and transferred to 39.5 °C and incubated for 2 h. In some of the immunoblotting experiments, the heat-treated cells were co-incubated with the proteasomal inhibitors 20 µM ALLN, 20 µM ALLM(13) , or 200 µM primaquine(16) . In metabolic labeling experiments and pulse-chase experiments, cells were labeled for 2 h in methionine-depleted normal media containing [S]methionine (100 µCi/ml) at the indicated temperature. Cells were chased in normal media supplemented with 2 mM methionine at the indicated temperature.

Ubiquitin Conjugation Assay

The ubiquitin conjugation activity in cellular extracts was used as a measure of E1 activity. Lysates were prepared from parental E36 cells or ts20 cells in ice-cold 20 mM Tris-HCl, pH 7.2, 0.25% Triton X-100, and 2 mM dithiothreitol, collected, incubated on ice for 20 min, and then centrifuged. Equal aliquots of protein as determined by the Bio-Rad protein assay (17) were incubated with I-ubiquitin at 30.5 °C in the presence or absence of added ATP. These aliquots were analyzed as outlined in Handley-Gearhart et al.(18) to measure ubiquitin conjugation activity.

Immunoblot

ts20 or E36 cells were washed with PBS and harvested by scraping. The cells were concentrated by centrifugation (1330 times g, 5 min) and ruptured by sonication (4 times 15 s). The cellular residue was concentrated by centrifugation (14,000 times g, 10 min), and then resuspended in PBS. The protein concentration of these extracts was determined(17) , and 20- or 5-µg aliquots were separated by SDS-PAGE on 12.5% polyacrylamide gels (19) and blotted onto Immobilon-P (Millipore, Bedford, MA)(20) . Membranes were blocked in 2% gelatin in PBS with 0.5% Triton X-100 for 16 h, incubated for 2 h in monoclonal anti-Cx43 antibodies (5 µg/ml), washed 4 times in PBS with 0.5% Triton X-100, incubated with a peroxidase-conjugated monospecific goat anti-mouse IgG antibodies (Jackson Immunoresearch, West Grove, PA), washed, and developed with the ECL chemiluminescence reagents (Amersham Corp.) and exposed to X-Omat film (Eastman Kodak Co.).

Immunofluorescent Labeling of Cultured Cells

Cells were cultured in plastic chamber microscope slides (Nunc, Naperville, IL), fixed in 50% methanol, 50% acetone for 2 min at room temperature, and permeabilized in 1% Triton X-100/PBS. Cells were incubated in a primary antibody (mouse monoclonal anti-Cx43) at 1:400 dilution overnight at 4 °C and secondary antibodies (CY3-conjugated goat anti-mouse IgG) (Jackson Immunoresearch, West Grove, PA) at 1:800 dilution for 1 h at room temperature with intervening washes. The cells were viewed on a Nikon Optiphot microscope at using a 60times (NA 1.4) objective and epifluorescence(21) .

Immunoprecipitation

Cultures of ts20 cells and E36 cells were processed for immunoprecipitation as outlined in Laing et al.(21) . Cells were metabolically labeled with [S]methionine and then were lysed by boiling in RIPA buffer, (PBS containing 1% Triton X-100, 0.6% SDS, 100 µ/ml aprotinin, 0.5 mg/ml pefabloc, 0.5 µg/ml leupeptin, 0.5 mg/ml EDTA, 50 µg/ml antipain, 50 µg/ml bestatin, 1 µg/ml E-64, 10 mM NaF, 10 mM NaVO(4)). This material was then centrifuged at 14,000 times g for 15 min to remove the insoluble material. In other experiments, immunoprecipitated material was resolubilized by boiling in 1 ml of RIPA buffer for 3 min and reacted with monoclonal antibodies directed against ubiquitin, and these antibody-antigen complexes were precipitated with immobilized anti-mouse IgG (Pierce, Rockford, IL).

Densitometric Analysis

Densitometric images were generated by using a Dage-MTI CCD72 camera (Dage) and digitized with a Matrox MVP image processing board. Gray scale values were obtained by using an FL-4000 (Georgia Instruments). The relative amount of Cx43 in each experiment was calculated by subtracting the background gray scale value from the gray scale value in each experiment. In pulse-chase experiments, the gray scale value was normalized to unchased values (which were assigned the value of 1). The first-order decay constant (k) was calculated for the different treatments from the first-order decay curves of the form y = e were generated with the program ENZFITTER. The half-life of the protein was determined using the formula t = 0.693/k(9) .


RESULTS

To determine possible mechanisms of Cx43 degradation, we treated E36 or BWEM cells with several different protease inhibitors and determined Cx43 levels by immunoblotting and densitometry. (Similar results were seen with both cell lines; those obtained using E36 cells are shown in Fig. 1). Cells were treated for 16 h with either the lysosomotropic amine, primaquine (200 µM), or two inhibitors of neutral cysteine proteases, ALLN (20 µM) and ALLM (20 µM). ALLN and ALLM are similar and can both inhibit calpain and cathepsin D; however, at the concentrations used, only ALLN inhibits proteasomal degradation(13) . The electrophoretic mobilities of Cx43 were similar in control and treated samples. The amount of Cx43 was modestly increased (2-fold) in E36 cells treated with primaquine (200 µM) as compared with control cultures (Fig. 1, lanes 1 and 2). E36 cells treated with ALLM contained similar amounts of Cx43 to control cultures (1.2 times as much by densitometry) (Fig. 1, lanes 1 and 4). In contrast, E36 cells treated with ALLN contained 6 times as much Cx43 as control cultures (Fig. 1, lane 3). These data suggested that proteasomal degradation might be the major route of Cx43 proteolysis.


Figure 1: Immunoblot analysis of E36 cells treated with various reagents. Cultures of E36 cells (60-80% confluent) were not treated (lane 1) or were treated with 200 µM primaquine (lane 2), 20 µM ALLN (lane 3), or 20 µM ALLM (lane 4). These cells were harvested, and 5-µg aliquots of each were resolved on a 10% polyacrylamide gel and transferred to Immobilon-P. These membranes were probed with the anti-Cx43 monoclonal antibody and detected by chemiluminescence.



To further test mechanisms of Cx43 degradation, cells were labeled with [S]methionine for 2 h and then were chased with fresh medium containing 2 mM methionine in the presence or absence of protease inhibitors. The cells were harvested and Cx43 was immunoprecipitated and analyzed by electrophoresis and fluorography. Fig. 2shows the results of a representative pulse-chase experiment in control E36 cells or primaquine-treated E36 cells. Cx43 was detected as a doublet at 42 and 44 kDa, and the amount of [S]methionine-labeled Cx43 diminished throughout the labeling period in both control and primaquine-treated cultures. Densitometric quantitation of these immunoprecipitations showed that the half-life of Cx43 was 2.5 h in the control and 3 h in the primaquine-treated cultures. While the turnover of Cx43 differed only mildly, examination of total [S]methionine-labeled proteins by SDS-PAGE and fluorography confirmed that the primaquine had inhibited the degradation of many other cellular proteins (data not shown).


Figure 2: Pulse-chase analysis of Cx43 turnover in normal and primaquine-treated cells. Cultures were labeled for 2 h with [S]methionine (100 µCi/ml) and chased for 0-4 h in normal media with or without 200 µM primaquine. All cultures were immunoprecipitated with anti-Cx43 antisera and then analyzed by SDS-PAGE and fluorography (inset). The fluorographs were analyzed by densitometry, and the relative amounts of Cx43 found at each time point are shown on the graph. The solid line represents data from control cultures, while results from primaquine treated cultures are shown as a dashed line.



In contrast, the turnover of Cx43 was significantly prolonged by the proteasomal inhibitor ALLN in both cell lines. The amount of Cx43 immunoprecipitated from E36 cells chased for 3-6 h in the presence of 20 µM ALLN was not significantly different from that at the beginning of the chase period (data not shown). Experiments with the chase period extended to 24 h showed that the Cx43 protein had a half-life of 9 h in BWEM cells (Fig. 3). Taken together, these immunoblot and pulse-chase experiments suggested that there was limited involvement of lysosomal proteolysis but a major role of the proteasome in Cx43 degradation in these cells.


Figure 3: Pulse-chase analysis of Cx43 turnover in normal and ALLN treated cells. Cultures of BWEM cells were labeled for 2 h with [S]methionine (100 µCi/ml) and chased for 0-24 h in normal media, with or without 20 µM ALLN, immunoprecipitated with anti-Cx43 antisera and then analyzed by SDS-PAGE and fluorography (inset). The fluorographs were analyzed by densitometry, and the relative amounts of Cx43 found at each time point are depicted graphically. Data from control cultures are represented by the solid line, while those from ALLN-treated cultures are shown as a dashed line.



The role of the ubiquitin-proteasome system in Cx43 degradation was examined in heat-treated ts20 and E36 cells. Heat treatment of many cells, including the E36 cells, leads to a stress-induced degradation of many cellular proteins. But heat treatment (44 °C for 1 h followed by 2 h at 39.5 °C) of ts20 cells inactivates the thermolabile E1 enzyme and thereby inactivates the ubiquitin-conjugation system(10) , as we confirmed by an ATP-dependent ubiquitination assay in lysates of cultures of both E36 and ts20 cells (data not shown). Cellular lysates of heat-treated E36 and ts20 cells were analyzed by immunoblotting with a monoclonal antibody directed against Cx43 (Fig. 4). Untreated ts20 and E36 cells contained similar amounts of Cx43 detected as a major band of 42 kDa (Fig. 4, lanes 1 and 2). Much less Cx43 was detected in heat-treated E36 cells (Fig. 4, lane 4). Inactivation of ubiquitination apparently prevented the loss of Cx43 in ts20 cells, since heat-treated ts20 cells retained a substantial fraction of the original amount of Cx43 (Fig. 4, lane 3). The loss of Cx43 was blocked in E36 cells that were heat-treated in the presence of ALLN (Fig. 4, lane 5), but not ALLM (Fig. 4, lane 6). These results indicate that the proteolysis of Cx43 in heat-treated E36 cells is dependent on ubiquitination and the proteasome. In addition to these differences, the mobility of some of the Cx43 was reduced in heat-treated cells, suggesting changes in phosphorylation may accompany heat-treatment.


Figure 4: Immunoblot analysis of Cx43 content of untreated (lanes 1 and 2) or heat-treated (lanes 3-6) ts20 (lanes 1 and 3) or E36 (lanes 2, 4, 5, and 6) cells. Parallel cultures of E36 cells were heat-treated in the presence of 20 µM ALLN (lane 5) or 20 µM ALLM (lane 6). Cultures of ts20 or E36 cells were heat-treated (44 °C for 1 h followed by 2 h at 39.5 °C) or maintained at 30.5 °C, followed by harvesting preparation of cell lysates and analysis by immunoblotting with a monoclonal antibody directed against Cx43.



To examine the cellular location of Cx43 in these cells, cultures of E36 and ts20 cells were heat-treated, fixed, and permeabilized, and Cx43 was detected by immunofluorescence (Fig. 5). At permissive temperatures (30.5 °C), moderate amounts of Cx43 staining were found at appositional membranes between either ts20 or E36 cells (Fig. 5, A and C) as expected for a gap junctional protein. Heat treatment led to some reduction of the amount of Cx43 detected in the E36 cells; this residual staining was still apparent at the cell membrane (Fig. 5B). After heat treatment of the ts20 cells, the distribution of immunoreactive Cx43 appeared substantially different; while some of the staining appeared to be at appositional membranes, substantial cytoplasmic staining was also detected (Fig. 5D). This staining appeared to be diffuse within the cytoplasm.


Figure 5: Immunofluorescence analysis of Cx43 in untreated (A and C) or heat-treated (B and D) ts20 (A and B) and E36 (C and D) cells. Cultures of ts20 or E36 cells were heat-treated (as in Fig. 3) or maintained at 30.5 °C. Cultures were fixed and permeabilized and stained with a monoclonal antibody directed against Cx43 as detected by indirect immunofluorescence (bar = 50 µm).



We performed further pulse-chase experiments to confirm the reversibility of the accumulation of Cx43 induced by heat treatment, as would be predicted by the reversibility of E1 inactivation. Cultures of ts20 cells were incubated at 44 °C for 1 h, followed by incubation in the presence of [S]methionine in methionine-depleted media for 2 h at 39.5 °C. One culture was then harvested for immunoprecipitation, while parallel cultures were chased in normal media for 3 h at 39.5 or at 30.5 °C. After the chase period, cells were harvested and lysed in RIPA buffer, and Cx43 was immunoprecipitated and analyzed by SDS-PAGE and fluorography. The cells chased at 39.5 °C (Fig. 6, lane 3) contained comparable amounts of Cx43 (42 and 44 kDa bands) to the sample from the start of the chase (Fig. 6, lane 1), while the cells chased at 30.5 °C contained only 10% as much Cx43 (44 kDa band only) confirming that degradation of Cx43 was restored (Fig. 6, lane 2).


Figure 6: Reversibility of heat-induced block to Cx43 degradation in ts20 cells. Cultures of ts20 cells were incubated at 44 °C for 1 h followed by 2 h at 39 °C in the presence of [S]methionine (100 µCi/ml) in methionine-depleted media, after which Cx43 was immunoprecipitated from one culture (lane 1). Cultures were chased in normal media for 3 h at either 30.5 °C (lane 2) or 39.5 °C (lane 3), and then Cx43 was immunoprecipitated. The immunoprecipitated Cx43 was analyzed by SDS-PAGE and fluorography.



In order to detect evanescent polyubiquitinated forms of Cx43, we performed immunoprecipitation experiments using E36 cells that were metabolically labeled for 16 h with [S]methionine in the presence of ALLN to inhibit proteasomal activity. These cells were harvested in RIPA buffer and sequentially immunoprecipitated with antibodies directed against Cx43 followed by an anti-ubiquitin monoclonal antibody. The material immunoprecipitated by anti-Cx43 antibodies was detected as two major bands of 42 and 44 kDa after an overnight exposure (Fig. 7, lane 1). In contrast, subsequent immunoprecipitation with the anti-ubiquitin antibody precipitated a number of bands between 44 and 70 kDa (Fig. 7, lane 2) detected only after a much longer exposure (3 weeks). These bands were not seen when the immunoprecipitation was performed in the presence of an excess of competing ubiquitin (Fig. 7, lane 3). These results appeared similar to the ladders of ubiquitinated polypeptides detected with other substrates of the ubiquitin/proteasomal apparatus(22) .


Figure 7: Immunoprecipitation of Cx43-ubiquitin conjugates. E36 cells were metabolically labeled with [S]methionine for 16 h in the presence of ALLN (20 µM) and harvested for immunoprecipitation. Lysates were immunoprecipitated with a rabbit antiserum directed against Cx43 (lane 1); parallel cultures were immunoprecipitated with a rabbit antiserum directed against Cx43 followed by reprecipitation with a monoclonal antibody against ubiquitin (lane 2) or reprecipitation with an anti-ubiquitin monoclonal antibody in the presence of competing ubiquitin (100 µg/ml) (lane 3).




DISCUSSION

The major conclusion of this study is that the degradation of Cx43 is dependent upon ubiquitin and the proteasome. This conclusion is supported by several observations of E36, BWEM, and ts20 cells. First, Cx43 accumulated in E36 or BWEM cells treated with the proteasomal inhibitor ALLN, due to decreased turnover of the protein. Second, while in the normal E36 cells heat treatment induced degradation of Cx43, in heat-treated ts20 cells containing a thermolabile ubiquitination pathway, Cx43 remained abundant as assessed by immunoblotting, immunofluorescence, and immunoprecipitation. Third, the heat-induced degradation of Cx43 was blocked by the proteasomal inhibitor ALLN but not by equal concentrations of the related protease inhibitor ALLM. While calpains are inhibited by similar concentrations of both of these neutral cysteine protease inhibitors, the proteasome is inhibited much more effectively by ALLN than by ALLM(13) . Fourth, the blocked Cx43 degradation in heat-treated ts20 cells was reversible as assessed by pulse-chase experiments in which returning heat-treated ts20 cells to 30.5 °C restored the proteolysis of Cx43. Fifth, polyubiquitinated Cx43 conjugates were isolated from ALLN-treated E36 cells. These could serve as substrates for the proteasome. The rather long exposure time required for their detection and the necessity for inclusion of ALLN, suggested that the ubiquitinated forms of Cx43 may constitute only a small fraction of the total Cx43 pool and may have only a very short lifespan. Sixth, in ts20 cells stably transfected with a cDNA encoding the human E1 enzyme(18) , we have found that Cx43 does not accumulate after heat-treatment, (^2)confirming that the block to degradation in the ts20 cells is due to the lability of this enzyme.

Our data implicate ubiquitination and the proteasome in the degradation of a very hydrophobic plasma membrane protein, the gap junction protein Cx43. While ubiquitin modification has been implicated in a variety of cellular processes including regulating gene expression, cell cycle and division, the cellular stress response, modification of cell surface receptors, DNA repair, import of proteins into mitochondria, uptake of precursors into neurons, and the biogenesis of ribosomes, mitochondria, and peroxisomes, its exact role in most of these processes is unclear (23) . In contrast, the role of the ubiquitin modification in the proteasomal pathway of protein degradation has been extensively characterized, and polyubiquitination is a signal for the proteasome to recognize proteins marked for degradation(23) . Numerous cytoplasmic and nuclear proteins involved in signal transduction and cellular replication are substrates of the ubiquitin-proteasome pathway including N-myc, c-myc, c-fos, and p53 (24) . Several plasma membrane proteins, including the c-kit protein(25) , Ste6(26), and the T-cell antigen receptor(27) , are modified by polyubiquitin moieties. Mori et al.(28) have shown that proteolysis of another plasma membrane protein, the platelet-derived growth factor receptor, is dependent upon polyubiquitination. Taken together, these studies suggest that ubiquitin plays a role in degradation of proteins from many different compartments of the cell.

Our findings imply that polyubiquitination is the signal for Cx43 degradation, but the structural determinants of Cx43 ubiquitination are currently unknown. Cx43 ubiquitination is unlikely to be governed by the N-end rule(30) ; it contains ``stabilizing'' residues as its first two amino acids (methionine and glycine), and N-terminal microsequencing (30) indicates that the amino-terminal residue in Cx43 isolated from rat tissues is glycine. Cx43 might possibly be recognized by a similar ubiquitin protein ligase (E3) and ubiquitin-carrier protein (E2) to those needed to catalyze the proteolysis of another non-N-end rule protein, p53, which is a well known substrate of the ubiquitin proteasome pathway(31) . Some proteins that have short half-lives contain a sequence rich in proline, glutamic acid, serine, and threonine residues called a PEST sequence(32) . As discussed by Laird et al.(8) , potential PEST sequences are present in the Cx43 protein. These sequences may correlate with rapid degradation of PEST box bearing proteins and have recently been shown to play a role in the ubiquitination and degradation of Cln3 cyclin by the ubiquitin-conjugating enzyme Cdc34(33) .

We believe that the ubiquitin proteasome pathway may also be a major mechanism for the proteolysis of gap junctions and connexins in other systems. Our data demonstrate involvement of ubiquitination and the proteasome in the normal turnover of Cx43 in two different cell lines and in the accelerated degradation induced by heat stress. Studies of the proteolysis of connexin32 have suggested that this protein may be digested by calpains(34) . A Lewis lung carcinoma cell line major histocompatibility complex class I antigen contained an octapeptide differing only at a single position from a portion of mouse connexin37 (35) . These cells contained and expressed both mutant and wild-type connexin37 genes, but only the mutant connexin37 peptide was associated with the major histocompatibility complex class I complex(35) . Thus, this mutant connexin37 protein was proteolyzed by the ubiquitin proteasome pathway(13) . Immunohistochemical studies of cultured cardiac myocytes and heart tissue using anti-ubiquitin conjugate antibodies indicated the presence of ubiquitin conjugates in the intercalated disc(36) , further suggesting that components of intercellular junctions may be substrates of the proteasome.

Because we observed a 2-fold Cx43 accumulation and a minor prolongation of its half-life in the presence of primaquine, we cannot exclude any role for the endosomal/lysosomal pathway in Cx43 degradation. But, in contrast to our observations, the half-life of P-selectin, a membrane protein that is degraded in the lysosome, is extended significantly by lysosomotropic amines(37) . Therefore, we have concluded that the lysosome has only a minor role in Cx43 proteolysis. While we observed accumulation of Cx43 within the cytoplasm of heat-shocked ts20 cells, this staining appeared diffuse, not vesicular. In contrast, several previous morphological studies reported vesicular structures containing morphologically identifiable gap junctions called annular gap junctions; such studies suggested that gap junctions were internalized by endocytosis. Treatments that lead to a loss of morphologically identifiable gap junctions, such as tissue dissociation, ischemia, or anoxia in the liver increase the abundance of annular gap junctions(2) . In some tissue culture systems, these vesicles appear to be clathrin coated and associated with actin(38) , phagolysosomes(39) , or multi-vesicular ``complex structures''(40) . Further biochemical analyses in such systems will be required to test the generality of our conclusions.


FOOTNOTES

*
This work was supported by National Institutes of Health Grants HL45466 and EY08368. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Supported by a fellowship from the American Heart Association (Missouri Affiliate). To whom correspondence should be addressed: Div. of Pediatric Hematology/Oncology, Washington University School of Medicine, Box 8116, One Children's Place, St. Louis, MO 63110. Tel.: 314-454-2493; Fax: 314-454-2685.

An Established Investigator of the American Heart Association.

(^1)
The abbreviations used are: Cx43, connexin43; ALLM, N-acetyl-L-leucinyl-L-leucinyl-methioninal; ALLN, N-acetyl-L-leucyl-L-leucinyl-norleucinal; PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis.

(^2)
J. G. Laing and E. C. Beyer, unpublished observations.


ACKNOWLEDGEMENTS

We thank Dr. Alan Schwartz and several members of his laboratory, including Julie Trausch-Azar and Dr. Patricia Handley-Gearhart, for advice and assistance with several of the experiments.


REFERENCES

  1. Beyer, E. C. (1993) Int. Rev. Cytol. 137, 1-37
  2. Traub, O., Druge, P. M., and Willecke, K. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 755-759 [Abstract]
  3. Luke, R. A., and Saffitz, J. E. (1991) J. Clin. Invest. 87, 1594-1602 [Medline] [Order article via Infotrieve]
  4. Cole, R. W., and Garfield, R. E. (1985) in Gap Junctions (Spray, D. C., and Bennett, M. V. L., eds) pp. 215-230, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  5. Fallon, R. F., and Goodenough, D. A. (1981) J. Cell Biol. 90, 521-526 [Abstract]
  6. Traub, O., Look J., Dermietzel, R., Brummer, F., Hulser, D., and Willecke, K. (1989) J. Cell Biol. 108, 1039-1051 [Abstract]
  7. Musil, L. S., Cunningham, B. A., Edelman, G. M., and Goodenough, D. A. (1990) J. Cell Biol. 111, 2077-2088 [Abstract]
  8. Laird, D. W., Puranam, K. L., and Revel, J. P. (1991) Biochem. J. 273, 67-72 [Medline] [Order article via Infotrieve]
  9. Darrow, B. J., Laing, J. G., Lampe, P. D., Saffitz, J. E., and Beyer, E. C. (1995) Circ. Res. 76, 381-387 [Abstract/Free Full Text]
  10. Gropper, R., Brandt, R. A., Elias, S., Bearer, C. F., Mayer, A., Schwartz, A. L., and Ciechanover, A. (1991) J. Biol. Chem. 266, 3602-3610 [Abstract/Free Full Text]
  11. Jariel-Encontre, I., Pariat, M., Martin, F., Carillo, S., Salvat, C., and Piechaczyk, M. (1995) J. Biol. Chem. 270, 11623-11627 [Abstract/Free Full Text]
  12. Bercovich, Z., Rosenberg-Hasson, Y., Ciechanover, A., and Kahana, C. (1989) J. Biol. Chem. 264, 15949-15952 [Abstract/Free Full Text]
  13. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Cell 78, 761-771 [Medline] [Order article via Infotrieve]
  14. Lenk, S. E., Dunn, W. A., Jr., Trausch, J. S., Ciechanover, A., and Schwartz, A. L. (1992) J. Cell Biol. 118, 301-308 [Abstract]
  15. Beyer, E. C., Kistler, J., Paul, D. L., and Goodenough, D. A. (1989) J. Cell Biol. 108, 595-605 [Abstract]
  16. Schwartz, A. L., Ciechanover, A., Merritt, S., and Turkewitz, A. (1986) J. Biol. Chem. 261, 15225-15232 [Abstract/Free Full Text]
  17. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  18. Handley-Gearhart, P. M., Trausch-Azar, J. S., Ciechanover, A., and Schwartz, A. L. (1994) Biochem. J. 304, 1015-1020 [Medline] [Order article via Infotrieve]
  19. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  20. Towbin, H., Staehelin, T., and Gordon, G. (1970) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354
  21. Laing, J. G., Westphale, E. M., Engelmann, G. L., and Beyer, E. C. (1994) J. Membr. Biol. 139, 31-40 [Medline] [Order article via Infotrieve]
  22. Madura, K., and Varshavsky, A. (1994) Science 265, 1454-1458 [Medline] [Order article via Infotrieve]
  23. Ciechanover, A. (1994) Cell 79, 13-21 [Medline] [Order article via Infotrieve]
  24. Ciechanover, A., DiGiusseppe, J. A., Bercovich, B., Orian, A., Richter, J. D., Schwartz, A. L., and Brodeur, G. M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 139-143 [Abstract]
  25. Miyazawa, K., Toyama, K. Gotoh, A., Hendrie, P. C., Mantel, P., and Broxmeyer, H. E. (1994) Blood 83, 137-145 [Abstract/Free Full Text]
  26. Kölling, R., and Hollenberg, C. P. (1994) EMBO J. 13, 3261-3271 [Abstract]
  27. Hou, D., Cenciarelli, C., Jensen, J. P., Nguyen, H. B., and Weissman, A. M. (1994) J. Biol. Chem. 269, 14244-14247 [Abstract/Free Full Text]
  28. Mori, S., Heldin, C.-H., and Claesson-Welsh, L. (1992) J. Biol. Chem. 267, 6429-6434 [Abstract/Free Full Text]
  29. Varshavsky, A. (1992) Cell 69, 725-735 [Medline] [Order article via Infotrieve]
  30. Manjunath, C. K., Nicholson, B. J., Teplow, D., Hood, L., Page, E., and Revel, J.-P. (1987) Biochem. Biophys. Res. Commun. 142, 228-234 [Medline] [Order article via Infotrieve]
  31. Ciechanover, A., Shkedy, D., Oren, M., and Bercovich, B. (1994) J. Biol. Chem. 269, 9582-9589 [Abstract/Free Full Text]
  32. Rechsteiner, M. (1988) in Current Trends in the Study of Intracellular Protein Degradation. (Knecht, E., and Grisolia, S., eds) pp. 235-253, Springer International, Vizcaya, Spain
  33. Yaglom, J., Linskens, M. H. K., Sadis, S., Rubin, D. M., Futcher, B., and Finley, D. (1995) Mol. Cell. Biol. 15, 731-741 [Abstract]
  34. Elvira, M., Diez, J. A., Wang, K. K. W., and Villalobo, A. (1993) J. Biol. Chem. 268, 14294-14300 [Abstract/Free Full Text]
  35. Mandleboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. (1994) Nature 369, 67-71 [Medline] [Order article via Infotrieve]
  36. Hilenski, L. L., Terracio, L., Haas, A. L., and Borg, T. K. (1992) J. Histochem. Cytochem. 40, 1037-1042 [Abstract/Free Full Text]
  37. Green, S. A., Setiadi, H., McEver, R. P., and Kelly, R. B. (1994) J. Cell Biol. 124, 435-448 [Abstract]
  38. Larsen, W. J., Tung, H.-N., Murray, S. A., and Swenson, C. A. (1979) J. Cell Biol. 83, 576-587 [Abstract]
  39. Ginzberg, R. D., and Gilula, N. B. (1979) Dev. Biol. 68, 110-129 [Medline] [Order article via Infotrieve]
  40. Severs, N. J., Shovel, K. S., Slade, A. M., Powell, T., Twist, V. W., and Green, C. R. (1989) Circ. Res. 65, 22-42 [Abstract]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.